Skip to main content
. 2022 Sep 13;11:33. doi: 10.1186/s13741-022-00265-0

Table 3.

Patient characteristics associated with odds of receiving at least one preoperative screening test

Factor OR LL UL p value
Intercept 0.43 0.33 0.53 0.00
Age 1.01 1.00 1.01 0.00
Female 1.06 1.02 1.10 0.00
Not married 1.03 1.01 1.05 0.01
Service connected >50% 1.02 1.00 1.04 0.05
Native American (ref = white) 1.05 0.93 1.17 0.40
Asian 1.01 0.88 1.13 0.92
Black 1.04 1.01 1.07 0.00
Hawaiian 1.07 0.95 1.18 0.26
Race missing 0.98 0.93 1.03 0.44
Peptic ulcer 1.08 0.96 1.20 0.19
AIDS 1.42 1.30 1.54 0.00
Lymphoma 2.66 2.57 2.75 0.00
Metastatic cancer 3.42 3.36 3.48 0.00
Solid tumor no metastasis 0.94 0.91 0.96 0.00
Rheumatoid arthritis 1.25 1.19 1.31 0.00
Coagulopathy 1.42 1.36 1.48 0.00
Obesity 1.09 1.06 1.11 0.00
Weight loss 1.41 1.36 1.46 0.00
Fluid and electrolyte disorders 1.69 1.66 1.73 0.00
Blood loss anemia 1.39 1.29 1.48 0.00
Deficiency anemia 1.19 1.14 1.23 0.00
Alcohol abuse 1.12 1.06 1.18 0.00
Drug abuse 1.06 1.02 1.11 0.01
Psychosis 1.10 1.02 1.17 0.01
Depression 1.06 1.04 1.09 0.00
Congestive heart failure 1.22 1.18 1.26 0.00
Cardiac arrhythmia 1.32 1.29 1.34 0.00
Valvular disorder 1.23 1.18 1.28 0.00
Pulmonary circulation disorder 1.24 1.17 1.30 0.00
Peripheral vascular disorder 1.07 1.04 1.10 0.00
Hypertension 1.18 1.16 1.21 0.00
Hypertension with complications 1.12 1.08 1.15 0.00
Paralysis 1.19 1.12 1.27 0.00
Other neurological disorder 1.09 1.05 1.13 0.00
Chronic pulmonary disease 1.27 1.24 1.29 0.00
Diabetes melitus 1.07 1.04 1.10 0.00
Diabetes melitus with complications 1.14 1.11 1.17 0.00
Hypothyroidism 1.06 1.02 1.09 0.00
Renal failure 1.37 1.33 1.40 0.00
Liver disease 1.33 1.29 1.37 0.00